Angiotensin II and ROS reinforce one another and together with hyperglycemia activate epidermal growth factor receptor (EGFR)/Src/TGF-β1 signaling, driving ECM deposition and glomerulosclerosis [148]. This evidence concerns the gene EGFR and glomerulosclerosis.